Reactivation of hepatitis C virus caused by steroid monotherapy for sudden deafness
Clinical Journal of Gastroenterology · 2024
DOI: 10.1007/s12328-024-01944-9 ↗Kurz gefasst
Fallbericht in der Zeitschrift Clinical Journal of Gastroenterology, 2024. Verfasst von Hiroki Kaneko und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, 5200 Kihara, Kiyotake, Miy…. Hauptthemen laut MEDLINE: Prednisolone, Hearing Loss, Sudden, Virus Activation, Antiviral Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Miyazaki.
Abstract (Originalsprache)
Hepatitis C virus (HCV) reactivation has been reported to be caused due to several anticancer drugs and immunosuppressive agents; however, HCV reactivation after steroid monotherapy has rarely been reported. Here, we report the case of a 65-year-old Japanese man with HCV infection who developed HCV reactivation after the administration of prednisolone (PSL) for 6 days for sudden deafness. In the patient history, the positivity for anti-HCV antibody was observed, but serum level of HCV RNA was not measured. Two months after PSL administration, the patient experienced an alanine aminotransferase (ALT) flare and the serum level of HCV RNA was observed to be 6.2 log IU/mL; then, the patient was admitted to our hospital for hepatitis treatment. Based on the clinical course and laboratory findings, the patient was diagnosed with HCV reactivation. Although the ALT levels decreased spontaneously during follow-up, they did not drop to normal range; subsequently, sofosbuvir and ledipasvir treatments were started. A sustained virological response 24 weeks after the end of treatment was achieved. This case study suggests that HCV reactivation with hepatitis flare can occur even after a steroid monotherapy, and doctors should pay attention to HCV reactivation when administering PSL for patients with HCV infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Gastroenterology and Hepatology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, 5200 Kihara, Kiyotake, Miyazaki, 889-1692, Japan.
- Division of Gastroenterology and Hepatology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, 5200 Kihara, Kiyotake, Miyazaki, 889-1692, Japan. hiropon@med.miyazaki-u.ac.jp.
Förderung
- University of Miyazaki
Zitieren
APA
Kaneko, H., Ozono, Y., Iwakiri, H., Hatada, H., Uchiyama, N., Komaki, Y., Nakamura, K., Hasuike, S., Nagata, K., & Kawakami, H. (2024). Reactivation of hepatitis C virus caused by steroid monotherapy for sudden deafness. Clinical Journal of Gastroenterology. https://doi.org/10.1007/s12328-024-01944-9
Vancouver
Kaneko H, Ozono Y, Iwakiri H, Hatada H, Uchiyama N, Komaki Y, et al. Reactivation of hepatitis C virus caused by steroid monotherapy for sudden deafness. Clinical Journal of Gastroenterology. 2024. doi:10.1007/s12328-024-01944-9
BibTeX
@article{Kaneko2024,
author = {Kaneko, Hiroki and Ozono, Yoshinori and Iwakiri, Hisayoshi and Hatada, Hiroshi and Uchiyama, Naomi and Komaki, Yuri and Nakamura, Kenichi and Hasuike, Satoru and Nagata, Kenji and Kawakami, Hiroshi},
title = {Reactivation of hepatitis C virus caused by steroid monotherapy for sudden deafness},
journal = {Clinical Journal of Gastroenterology},
year = {2024},
doi = {10.1007/s12328-024-01944-9}
}
EUVIMED